Organogenesis Holdings (ORGO) Enterprise Value (2015 - 2026)

Organogenesis Holdings' Enterprise Value history runs 12 years deep, the most recent figure standing at -$92.1 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 16.68% year-over-year to -$92.1 million; the TTM figure through Mar 2026 stood at -$92.1 million (up 16.68% YoY), while the FY2025 annual figure was -$94.3 million, up 30.72% from the prior year.
• Enterprise Value was -$92.1 million for Q1 2026 at Organogenesis Holdings, up from -$94.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$68.1 million in Q3 2025 to a low of -$136.2 million in Q4 2024.
• Historically, Enterprise Value has averaged -$98.2 million across 5 years, with a median of -$94.9 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Enterprise Value sank 22080.9% in 2022, then jumped 30.72% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$103.3 million in 2022, then fell by 1.01% to -$104.3 million in 2023, then plunged by 30.49% to -$136.2 million in 2024, then surged by 30.72% to -$94.3 million in 2025, then gained by 2.37% to -$92.1 million in 2026.
• The last three Enterprise Value figures came in at -$92.1 million (Q1 2026), -$94.3 million (Q4 2025), and -$68.1 million (Q3 2025), per Business Quant data.